The majority of Cnverg’s squad might be in Texas now, but they’re still (and will always be) Delaware nice. They’re on the front page of Product Hunt this morning. Give ’em some love.
Upvote itFrom lab space and coffee bars to jobs and long-term returns, mid-tier life sciences hubs may be better positioned than the biggest biotech boomtowns.
Philadelphia venture firm Osage University Partners will manage the capital, only available to university-affiliated companies.
Ecosystem leaders chimed in about what they see happening in the year ahead. More intentional personal connections is a goal for many.
Disruptions to SBIR/STTR program leave local life sciences and tech innovators facing tougher paths to commercialization.
The Philly-based biotech is developing a GLP-1 that aims to help patients lose weight and keep it off.
The Pittsburgh startup’s tech takes an updated approach to keep AI chips from getting too hot.
Something went wrong. Please refresh the page and/or try again.
